Clearmind Medicine Inc. to Present at the Q1 Virtual Investor Summit

Vancouver, BC--(Newsfile Corp. - February 28, 2022) - Clearmind Medicine Inc. (CSE:CMND) today announced that Dr. Adi Zuloff-Shani, CEO will be attending the Q1 Virtual Investor Summit. Clearmind's CEO will present highlights of the Company, including its plans for clinical stage trials with MEAI, a novel psychedelic, for the treatment of alcohol use disorder.

Event: Q1 Investor Summit

Date: March 8-9th, 2022

Presentation: March 8th at 11:45 am ET

Location: https://us06web.zoom.us/webinar/register/WN_1tBpa6rrTtKuvB-J1EAoRA

• 1x1s will be available for qualified investors
• The conference is completely complimentary to qualified investors. Please register at Complimentary Investor Registration

About Clearmind Medicine Inc.

Clearmind is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods or supplements.The Company’s intellectual portfolio currently consists of four patent families. The Company intends to seek additional patents for its compounds whenever warranted and willremain opportunistic regarding the acquisition of additional intellectual property to build its portfolio. Shares of Clearmind are listed for trading on theCanadian Securities Exchange under the symbol "CMND", the Frankfurt Stock Exchange under the symbol“CWYO” and on the OTC pink under the symbol "CMNDF".

For further information:

Clearmind Medicine Inc.
Vahid Eghtesad
6042601566
invest@clearmindmedicine.com

About the Investor Summit

The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q1 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: info@investorsummitgroup.com